With backing from some of biotech’s biggest players, Alector, a startup taking on Alzheimer’s disease announced Wednesday that it has raised $133 million in a Series E funding round.
AbbVie-Backed Startup Raises $133 Million To Fight Alzheimer’s With Immunotherapy
